Rock Springs Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-151,000
| Closed | -$10.6M | – | 110 |
|
|
2024
Q3 | $10.6M | Hold |
151,000
| – | – | 0.35% | 66 |
|
|
2024
Q2 | $12.4M | Buy |
151,000
+2,168
| +1% | +$178K | 0.37% | 65 |
|
|
2024
Q1 | $13M | Hold |
148,832
| – | – | 0.33% | 72 |
|
|
2023
Q4 | $14.4M | Sell |
148,832
-115,668
| -44% | -$11.2M | 0.35% | 65 |
|
|
2023
Q3 | $23.4M | Hold |
264,500
| – | – | 0.63% | 53 |
|
|
2023
Q2 | $22.9M | Hold |
264,500
| – | – | 0.55% | 55 |
|
|
2023
Q1 | $25.7M | Hold |
264,500
| – | – | 0.61% | 51 |
|
|
2022
Q4 | $27.4M | Hold |
264,500
| – | – | 0.66% | 48 |
|
|
2022
Q3 | $22.4M | Hold |
264,500
| – | – | 0.58% | 51 |
|
|
2022
Q2 | $21.9M | Hold |
264,500
| – | – | 0.64% | 47 |
|
|
2022
Q1 | $20.4M | Buy |
264,500
+500
| +0.2% | +$38.6K | 0.51% | 59 |
|
|
2021
Q4 | $23.3M | Buy |
264,000
+10,500
| +4% | +$928K | 0.54% | 59 |
|
|
2021
Q3 | $19.6M | Hold |
253,500
| – | – | 0.41% | 74 |
|
|
2021
Q2 | $21.2M | Hold |
253,500
| – | – | 0.42% | 72 |
|
|
2021
Q1 | $19.1M | Hold |
253,500
| – | – | 0.42% | 74 |
|
|
2020
Q4 | $22.2M | Sell |
253,500
-96,500
| -28% | -$8.46M | 0.47% | 73 |
|
|
2020
Q3 | $26.6M | Sell |
350,000
-37,500
| -10% | -$2.85M | 0.68% | 47 |
|
|
2020
Q2 | $47.8M | Buy |
387,500
+7,500
| +2% | +$925K | 1.31% | 22 |
|
|
2020
Q1 | $32.1M | Buy |
380,000
+42,500
| +13% | +$3.59M | 1.33% | 27 |
|
|
2019
Q4 | $28.5M | Buy |
337,500
+195,000
| +137% | +$16.5M | 0.9% | 46 |
|
|
2019
Q3 | $9.61M | Hold |
142,500
| – | – | 0.38% | 79 |
|
|
2019
Q2 | $12.2M | Buy |
142,500
+7,500
| +6% | +$642K | 0.44% | 76 |
|
|
2019
Q1 | $12M | Buy |
135,000
+6,000
| +5% | +$533K | 0.46% | 72 |
|
|
2018
Q4 | $11M | Buy |
129,000
+4,000
| +3% | +$341K | 0.52% | 64 |
|
|
2018
Q3 | $12.1M | Hold |
125,000
| – | – | 0.44% | 74 |
|
|
2018
Q2 | $11.8M | Hold |
125,000
| – | – | 0.45% | 76 |
|
|
2018
Q1 | $10.1M | Hold |
125,000
| – | – | 0.43% | 78 |
|
|
2017
Q4 | $11.1M | Hold |
125,000
| – | – | 0.51% | 69 |
|
|
2017
Q3 | $11.6M | Hold |
125,000
| – | – | 0.54% | 62 |
|
|
2017
Q2 | $11.4M | Hold |
125,000
| – | – | 0.57% | 58 |
|
|
2017
Q1 | $11M | Hold |
125,000
| – | – | 0.63% | 51 |
|
|
2016
Q4 | $10.4M | Hold |
125,000
| – | – | 0.69% | 48 |
|
|
2016
Q3 | $11.6M | Buy |
125,000
+12,000
| +11% | +$1.11M | 0.73% | 48 |
|
|
2016
Q2 | $8.79M | Buy |
113,000
+9,750
| +9% | +$759K | 0.65% | 48 |
|
|
2016
Q1 | $8.52M | Buy |
103,250
+33,250
| +48% | +$2.74M | 0.71% | 43 |
|
|
2015
Q4 | $7.33M | Buy |
70,000
+19,500
| +39% | +$2.04M | 0.56% | 63 |
|
|
2015
Q3 | $5.32M | Buy |
50,500
+18,000
| +55% | +$1.9M | 0.43% | 76 |
|
|
2015
Q2 | $4.45M | Hold |
32,500
| – | – | 0.32% | 96 |
|
|
2015
Q1 | $4.05M | Buy |
+32,500
| New | +$4.05M | 0.38% | 84 |
|